Stay updated on Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    A new release entry, Revision: v3.6.3, has been added to the study record's version history, following the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-04T04:52:50.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The study history now includes a new revision entry v3.6.2 and removes the older v3.6.0 from the visible history. This updates the version record shown on the page.
    Difference
    0.1%
    Check dated 2026-06-27T03:23:07.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study is no longer looking for participants, indicating enrollment has halted. The history also shows a new revision labeled v3.6.0 and the previous revision v3.5.5 has been removed from the record history.
    Difference
    0.6%
    Check dated 2026-06-12T17:23:54.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new revision entry v3.5.5 was added to the record history to replace the previous revision v3.5.4, indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-06-05T17:17:14.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The record history shows a new latest revision (v3.5.4) replacing the previous (v3.5.3), indicating an update to the page's text and layout captured in the revision.
    Difference
    0.1%
    Check dated 2026-05-15T05:40:46.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page footer updates the displayed software revision from v3.5.2 to v3.5.3, reflecting a minor system/interface update rather than a change to the trial’s record history.
    Difference
    0.1%
    Check dated 2026-04-24T05:50:34.000Z thumbnail image

Stay in the know with updates to Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab Plus Tislelizumab vs Durvalumab in cCRT Clinical Trial page.